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Cardiovascular disease remains the leading cause of death around the world.1 A major cause is atherogenic dyslip-
idemia, which is characterized by increased concentrations of 
triglyceride-rich lipoproteins and is seen in subjects with obe-
sity and type 2 diabetes mellitus. Increased hepatic secretion 
of triglyceride-rich very-low-density lipoproteins (VLDL) is a 
major determinant of the hypertriglyceridemia.2 The produc-
tion of VLDL from the liver is a complex process. It starts 
with the formation of nascent lipoprotein particles that are fur-
ther lipidated in the secretory pathway, resulting in the genera-
tion of triglyceride-rich VLDL particles that are secreted from 
the liver.3 It is therefore not surprising that VLDL secretion—
and thus the concentration of plasma triglycerides—is highly 
dependent on the availability of hepatic lipids.4,5
See accompanying article on page 633
Cellular lipids are stored in lipid droplets (LDs) consisting 
of a core of neutral lipids (mainly triglycerides and choles-
teryl esters), surrounded by phospholipids and proteins.3 Both 
lipids and proteins are synthesized in a membranous structure 
of the cell called the endoplasmic reticulum (ER). The ER 
compartment is also involved in quality control, as it identifies 
misfolded proteins that are degraded through ER-associated 
degradation or autophagic degradation.6
Interestingly, recent studies have shown that LDs are 
not only involved in lipid storage but are also important 
for proteasomal protein degradation and autophagy.7 The 
AUP1 (ancient ubiquitous protein 1) was identified as 
the first LD-associated protein involved in ER-associated 
degradation.7 The carboxyl terminus of AUP1 binds the 
E2 ubiquitin conjugases.8 Thus, AUP1 provides a direct 
molecular link between LDs and ubiquitination-mediated 
degradation of misfolded ER proteins. In addition, AUP1 
also controls lipid synthesis as it induces ubiquitination and 
the subsequent degradation of several key regulators of lipid 
biosynthesis, such as the cholesterol biosynthetic enzyme 
3-hydroxy-3-methylglutaryl-coenzyme A reductase.9 The 
expression of AUP1, therefore, affects the amount and size 
of LDs. Thus, AUP1 has dual roles in protein quality control 
and LD regulation.7
In this issue of Arteriosclerosis, Thrombosis, and Vascular 
Biology, Zhang et al10 significantly extend these studies and 
for the first time demonstrated that AUP1 is a key determinant 
of hepatic VLDL assembly and secretion. AUP1 was found 





sion of AUP1 increased triglyceride biosynthesis and the 
average size of cytosolic LDs, decreased post-translational 
degradation of apoB100, and enhanced section of mature 
triglyceride-rich VLDL from the human hepatoma cells 
HepG2 (Figure). These cells normally secrete smaller under-
lipidated apoB-containing lipoproteins instead of fully lipi-
dated VLDL particles, and suppression of AUP1corrected this 
metabolic defect. Thus, AUP1 plays critical roles in intracel-
lular lipid metabolism, apoB stability, and VLDL assembly 
and secretion.
How does suppression of AUP1 correct the defective 
VLDL assembly in HepG2 cells? The conversion of triglyc-
eride-poor to triglyceride-rich VLDL has been proposed to 
require a bulk addition of triglycerides derived from cytosolic 
LDs.11–14 Thus, it could be hypothesized that to retain lipids 
intracellularly instead of secreting triglyceride-rich VLDL, 
HepG2 hepatoma cells overexpress AUP1, which accumulates 
on LDs in the later part of the secretory pathway. Accumulation 
of AUP1 in LDs would hamper VLDL assembly.
Does AUP1 play a physiological role in VLDL secretion 
in nonhepatoma cells? This was not analyzed in this study. 
However, the expression of AUP1 has been measured in 
human liver samples obtained from a separate cohort of 12 
obese subjects with increased liver fat content who under-
went bariatric surgery,15 and compared with AUP1 gene 
expression in liver samples obtained from 7 healthy individ-
uals.16 This comparison showed that the mRNA expression 
of AUP1 was significantly lower in liver from obese sub-
jects than from healthy subjects (adjusted P value <0.05). 
These results may indicate that the regulation of AUP1 is 
impaired in subjects with nonalcoholic fatty liver disease 
and type 2 diabetes mellitus. Future studies are needed to 
address this in detail and to clarify whether AUP1 is linked 
to the altered hepatic lipid metabolism and increased VLDL 
secretion seen in subjects with nonalcoholic fatty liver dis-
ease and type 2 diabetes mellitus. If this turns out to be the 
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Figure. Impact of AUP1 (ancient ubiquitous protein 1) on lipid 
biogenesis and very low-density lipoproteins (VLDL) assembly. 
A, ApoB is synthesized and cotranslationally lipidated to form 
a pre-VLDL particle. Alternatively, apoB fails to be lipidated 
and is incorrectly folded and sorted to degradation. The forma-
tion of mature triglyceride-rich VLDL is dependent on the bulk 
addition of triglycerides derived from cytosolic lipid droplets 
(LDs). B, If AUP1 is overexpressed, more pre-VLDL particles 
are sorted to post-translational degradation. Likewise, accu-
mulation of AUP1 on LDs may hamper apoB lipidation and 
VLDL assembly. Thus, fewer VLDL particles are formed. C, 
When AUP1 is decreased, fewer apoB-containing lipoproteins 
are sorted to post-translational degradation and more LDs 
are formed. Thus, more mature VLDL particles are secreted 
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